NN1471 / Novo Nordisk - LARVOL DELTA

A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump (clinicaltrials.gov) - P1 | N=43 | Recruiting | Sponsor: Novo Nordisk A/S

New P1 trial • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump (clinicaltrials.gov) - P1 | N=19 | Completed | Sponsor: Novo Nordisk A/S | Active, not recruiting ➔ Completed | N=29 ➔ 19

Enrollment change • Trial completion • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump (clinicaltrials.gov) - P1 | N=29 | Active, not recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Active, not recruiting | Trial primary completion date: Mar 2022 ➔ Sep 2022

Enrollment closed • Trial primary completion date • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump (clinicaltrials.gov) - P1 | N=29 | Not yet recruiting | Sponsor: Novo Nordisk A/S

New P1 trial • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus

A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus (clinicaltrials.gov) - P1; N=48; Completed; Sponsor: Novo Nordisk A/S; Recruiting ➔ Completed

Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus